-
  • Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation.

    1 januari 1970 | Pubmed | whoisjjc_k77083ou
  • Related Articles

    Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation.

    J Pharmacol Sci. 2016 Jun;131(2):84-92

    Authors: Park J, Yeom M, Hahm DH

    Abstract
    Hyperlipidemia is associated with increased risk of the development of cardiovascular diseases. Although a great deal of attention has been paid to the hypolipidemic activity of fucoidan, complex polysaccharides from Lees meer

    Source:: Pubmed